Humana (HUM) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Currently, no data available

Based on NaN analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

There Are No Analyst Ratings for CH:HUM In The Last 3 Months.

Highest Price Target―

Average Price Target―

Lowest Price Target―

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is -$3.20 with a range of -$3.50 to -$2.85. The previous quarter’s EPS was $2.61. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $25.84B with a range of $25.34B to $26.13B. The previous quarter’s sales results were $26.34B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts

Erin Wright

Morgan Stanley

CHF222.95

Hold

―

Reiterated

11/06/25

Humana's Strategic Focus on Medicare Advantage and Future Margin Expansion Amidst Uncertain Guidance

David S Macdonald

Truist Financial

―

Hold

―

Reiterated

11/06/25

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), LENZ Therapeutics (NASDAQ: LENZ) and Lifestance Health Group (NASDAQ: LFST)

Michael Wiederhorn

Oppenheimer

CHF249.51

Buy

―

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

CHF241.46

Hold

―

Reiterated

11/06/25

Humana's Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges

Soren Coverra

TR | OpenAI - 4o

CHF249.51→CHF233.41

Hold

―

Downgraded

11/06/25

AI Generated ArticleAI Generated Article

Sarah James

Cantor Fitzgerald

CHF233.41

Hold

―

Reiterated

11/05/25

Cantor Fitzgerald Keeps Their Hold Rating on Humana (HUM)

Elizabeth Anderson CFA

Evercore ISI

CHF237.44

Hold

―

Reiterated

11/05/25

Jason Cassorla

Guggenheim

CHF262.39

Buy

―

Reiterated

10/20/25

Humana (HUM) Gets a Buy from Guggenheim

Lance Wilkes

Bernstein

CHF274.46

Buy

―

Reiterated

10/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben Hendrix

RBC Capital

CHF259.17

Buy

―

Reiterated

10/15/25

Humana (HUM) Gets a Buy from RBC Capital

Andrew Mok CFA

Barclays

CHF197.19

Hold

―

Reiterated

10/15/25

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (NASDAQ: APLS), Impedimed Limited (Other OTC: IPDQF) and Humana (NYSE: HUM)

Scott Fidel

Goldman Sachs

CHF233.94

Sell

―

Initiated

10/14/25

Goldman Sachs Initiates a Sell Rating on Humana (HUM)

Whit Mayo

Leerink Partners

CHF219.73

Hold

―

Reiterated

10/10/25

Humana (HUM) Receives a Hold from Leerink Partners

Ann Hynes

Mizuho Securities

CHF241.46→CHF277.68

Buy

―

Reiterated

10/08/25

Humana price target raised to $345 from $300 at MizuhoHumana price target raised to $345 from $300 at Mizuho

Justin Lake

Wolfe Research

CHF227.78→CHF251.93

Buy

―

Reiterated

10/06/25

Humana (HUM) Gets a Buy from Wolfe Research

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Erin Wright

Morgan Stanley

CHF222.95

Hold

―

Reiterated

11/06/25

Humana's Strategic Focus on Medicare Advantage and Future Margin Expansion Amidst Uncertain Guidance

David S Macdonald

Truist Financial

―

Hold

―

Reiterated

11/06/25

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), LENZ Therapeutics (NASDAQ: LENZ) and Lifestance Health Group (NASDAQ: LFST)

Michael Wiederhorn

Oppenheimer

CHF249.51

Buy

―

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

CHF241.46

Hold

―

Reiterated

11/06/25

Humana's Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges

Soren Coverra

TR | OpenAI - 4o

CHF249.51→CHF233.41

Hold

―

Downgraded

11/06/25

AI Generated ArticleAI Generated Article

Sarah James

Cantor Fitzgerald

CHF233.41

Hold

―

Reiterated

11/05/25

Cantor Fitzgerald Keeps Their Hold Rating on Humana (HUM)

Elizabeth Anderson CFA

Evercore ISI

CHF237.44

Hold

―

Reiterated

11/05/25

Jason Cassorla

Guggenheim

CHF262.39

Buy

―

Reiterated

10/20/25

Humana (HUM) Gets a Buy from Guggenheim

Lance Wilkes

Bernstein

CHF274.46

Buy

―

Reiterated

10/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben Hendrix

RBC Capital

CHF259.17

Buy

―

Reiterated

10/15/25

Humana (HUM) Gets a Buy from RBC Capital

Andrew Mok CFA

Barclays

CHF197.19

Hold

―

Reiterated

10/15/25

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (NASDAQ: APLS), Impedimed Limited (Other OTC: IPDQF) and Humana (NYSE: HUM)

Scott Fidel

Goldman Sachs

CHF233.94

Sell

―

Initiated

10/14/25

Goldman Sachs Initiates a Sell Rating on Humana (HUM)

Whit Mayo

Leerink Partners

CHF219.73

Hold

―

Reiterated

10/10/25

Humana (HUM) Receives a Hold from Leerink Partners

Ann Hynes

Mizuho Securities

CHF241.46→CHF277.68

Buy

―

Reiterated

10/08/25

Humana price target raised to $345 from $300 at MizuhoHumana price target raised to $345 from $300 at Mizuho

Justin Lake

Wolfe Research

CHF227.78→CHF251.93

Buy

―

Reiterated

10/06/25

Humana (HUM) Gets a Buy from Wolfe Research

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month

xxx

Success Rate

25/39 ratings generated profit

Average Return

+1.42%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 64.10% of your transactions generating a profit, with an average return of +1.42% per trade.

3 Months

xxx

Success Rate

27/39 ratings generated profit

Average Return

+2.43%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +2.43% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

25/39 ratings generated profit

Average Return

+4.80%

reiterated a buy rating 2 days ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 64.10% of your transactions generating a profit, with an average return of +4.80% per trade.

2 Years

xxx

Success Rate

30/39 ratings generated profit

Average Return

+11.77%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +11.77% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 17 Buy Ratings, 18 Hold Ratings, and 1 Sell Ratings. HUM average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

HUM Stock Forecast FAQ

What is CH:HUM’s average 12-month price target, according to analysts?

Currently, no data Available

What is CH:HUM’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:HUM, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Humana a Buy, Sell or Hold?

Currently, no data Available

What is Humana’s share price target?

Currently, no data Available

What do analysts say about Humana?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of Humana?

To buy shares of CH:HUM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts